FMR CORP Insider Trading $DNLI Denali Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for FMR CORP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of FMR CORP. FMR CORP is 10% Owner in ARCHIPELAGO HOLDINGS INC ($AX) and in EXA CORP ($EXA) and in PRECISION BIOSCIENCES INC ($DTIL) and in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and in Mersana Therapeutics, Inc. ($MRSN) and in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and in Coherus BioSciences, Inc. ($CHRS) and 10% Owner in Coherus BioSciences, Inc. ($CHRS) and in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and in Menlo Therapeutics, Inc. ($MNLO) and in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Dimension Therapeutics, Inc. ($DMTX) and in REGENXBIO Inc. ($RGNX) and 10% Owner in REGENXBIO Inc. ($RGNX) and in Blueprint Medicines Corp ($BPMC) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in ViewRay, Inc. ($VRAY) and 10% Owner in ViewRay, Inc. ($VRAY) and in Unum Therapeutics Inc. ($UMRX) and in Denali Therapeutics Inc. ($DNLI) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Beam Therapeutics Inc. ($BEAM) and 10% Owner in Orchard Therapeutics plc ($ORTX).

FMR CORP in Denali Therapeutics Inc.

Trading Symbol: DNLI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of FMR CORP:
Holdings: 2,841,896 shares
Latest Transaction: Dec 14 2017

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of FMR CORP in Denali Therapeutics Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACRS, AX, BEAM, BPMC, COGT, CHRS, DNLI, DMTX, EXA, MRSN, ORTX, DTIL, RGNX, SURF, TTPH, VRAY, MNLO, YMTX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.001,24600
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.0041,56100
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.00112,59000
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.0049800
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.0016,62400
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.0045,03500
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.0024,24000
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.00808,01300
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCOption ExerciseC0.002,188,86900
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.001,246033,21532 K to 33.2 K (+3.90 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.00498031,96931.5 K to 32 K (+1.58 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.0024,240031,4717.2 K to 31.5 K (+335.22 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.0041,56101,107,2571.1 M to 1.1 M (+3.90 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.0016,62401,065,6961 M to 1.1 M (+1.58 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.00808,01301,049,072241.1 K to 1 M (+335.19 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.00112,59002,999,5212.9 M to 3 M (+3.90 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.0045,03502,886,9312.8 M to 2.9 M (+1.58 %)
Dec 14 2017DNLIDenali Therapeutic ...FMR LLCBuyC0.002,188,86902,841,896653 K to 2.8 M (+335.19 %)

Page:   1